Processa Pharmaceuticals, Inc. (PCSA)

Processa Pharmaceuticals Statistics

Total Valuation

PCSA has a market cap or net worth of $17.33 million. The enterprise value is $11.06 million.

Market Cap	17.33M
Enterprise Value	11.06M

Important Dates

The last earnings date was Thursday, November 6, 2025, after market close.

Earnings Date	Nov 6, 2025
Ex-Dividend Date	n/a

Share Statistics

PCSA has 56.64 million shares outstanding. The number of shares has increased by 669.63% in one year.

Current Share Class	56.64M
Shares Outstanding	56.64M
Shares Change (YoY)	+669.63%
Shares Change (QoQ)	+205.25%
Owned by Insiders (%)	0.89%
Owned by Institutions (%)	17.46%
Float	51.02M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	2.48
P/TBV Ratio	2.98
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 3.76

Current Ratio	3.76
Quick Ratio	3.61
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -270.74% and return on invested capital (ROIC) is -168.65%.

Return on Equity (ROE)	-270.74%
Return on Assets (ROA)	-129.94%
Return on Invested Capital (ROIC)	-168.65%
Return on Capital Employed (ROCE)	-223.21%
Revenue Per Employee	n/a
Profits Per Employee	-$1.29M
Employee Count	10
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -69.70% in the last 52 weeks. The beta is 1.07, so PCSA's price volatility has been similar to the market average.

Beta (5Y)	1.07
52-Week Price Change	-69.70%
50-Day Moving Average	0.29
200-Day Moving Average	0.31
Relative Strength Index (RSI)	48.64
Average Volume (20 Days)	4,324,130

Short Selling Information

The latest short interest is 9.05 million, so 15.98% of the outstanding shares have been sold short.

Short Interest	9.05M
Short Previous Month	13.76M
Short % of Shares Out	15.98%
Short % of Float	17.74%
Short Ratio (days to cover)	0.41

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-13.02M
Pretax Income	-12.93M
Net Income	-12.93M
EBITDA	-13.02M
EBIT	-13.02M
Earnings Per Share (EPS)	-$0.66

Balance Sheet

The company has $6.31 million in cash and n/a in debt, giving a net cash position of $6.31 million or $0.11 per share.

Cash & Cash Equivalents	6.31M
Total Debt	n/a
Net Cash	6.31M
Net Cash Per Share	$0.11
Equity (Book Value)	5.83M
Book Value Per Share	0.11
Working Capital	4.84M

Cash Flow

Operating Cash Flow	-10.73M
Capital Expenditures	n/a
Free Cash Flow	-10.73M
FCF Per Share	-$0.19

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

PCSA does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-669.63%
Shareholder Yield	-669.63%
Earnings Yield	-74.47%
FCF Yield	-61.80%

Analyst Forecast

The average price target for PCSA is $1.00, which is 226.80% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$1.00
Price Target Difference	226.80%
Analyst Consensus	Strong Buy
Analyst Count	1
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on January 22, 2024. It was a reverse split with a ratio of 1:20.

Last Split Date	Jan 22, 2024
Split Type	Reverse
Split Ratio	1:20

Scores

Altman Z-Score	n/a
Piotroski F-Score	1